In silico design of novel FAK inhibitors using integrated molecular docking, 3D-QSAR and molecular dynamics simulation studies

被引:17
|
作者
Shirvani, Pouria [1 ]
Fassihi, Afshin [1 ,2 ]
机构
[1] Isfahan Univ Med Sci, Fac Pharm & Pharmaceut Sci, Dept Med Chem, Esfahan 81741673461, Iran
[2] Isfahan Univ Med Sci, Bioinformat Res Ctr, Esfahan, Iran
来源
关键词
FAK; cancer; 3D-QSAR; molecular docking; molecular dynamics simulation; MM-PBSA; FOCAL ADHESION KINASE; APPLICABILITY DOMAIN; DRUG DESIGN; VALIDATION; PREDICTIONS; EXPRESSION; INSIGHT; BINDING; CANCER; ERROR;
D O I
10.1080/07391102.2021.1875880
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays a crucial role in integrin signaling that regulates essential cellular functions including growth, motility, proliferation and survival in different types of cells. Interestingly, it has also shown to be up-regulated in various types of tumors, hence it has emerged as a significant therapeutic target for the development of selective inhibitors. In present work, with the aim of achieving further insight into the structural characteristics required for the FAK inhibitory activity, a combined approach of molecular modeling studies including molecular docking, three-dimensional quantitative structure activity relationship (3D-QSAR) and molecular dynamics (MD) simulation were carried out on a series of 7H-pyrrolo[2,3-d]pyrimidine and thieno[3,2-d]pyrimidine FAK inhibitors. The probable binding modes and interactions of inhibitors into the FAK active site were predicted by molecular docking. The 3D-QSAR models were developed using the comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods, with three ligand-based, docking-based and receptor-based alignment techniques. Both CoMFA and CoMSIA models obtained from receptor-based alignment were superior to the ones obtained by other alignment methods. However, the CoMSIA model (q(2) = 0.679, r(2) = 0.954 and r(2) (pred) = 0.888) depicted almost better predictive ability than the CoMFA model (q(2) = 0.617, r(2) = 0.932 and r(2) (pred) = 0.856). The contour map analysis revealed the relationship between the structural features and inhibitory activity. The docking results and CoMFA and CoMSIA contour maps were in good accordance. Based on the information obtained from the molecular docking and contour map analysis, a series of novel FAK inhibitors were designed that showed better predicted inhibitory activity than the most potent compound 31 in the data set. Finally, the stability of the reference molecule 31 and the designed compounds D15 and D27 were evaluated through a 30 ns of MD simulation and their binding free energies were calculated using the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method. The result of MD simulation and binding free energy decomposition demonstrated the important role of van der Waals interactions alongside H-bond ones that were in consistent with the docking and contour maps analysis results. In sum, the results from this study may provide a significant insight for developing more effective novel FAK inhibitors. Communicated by Ramaswamy H. Sarma
引用
收藏
页码:5965 / 5982
页数:18
相关论文
共 50 条
  • [21] In silico studies on potential TNKS inhibitors: a combination of pharmacophore and 3D-QSAR modelling, virtual screening, molecular docking and molecular dynamics
    Liu, Jianxin
    Feng, Kairui
    Ren, Yujie
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (14): : 3803 - 3821
  • [22] 3D-QSAR and molecular docking studies on HIV protease inhibitors
    Tong, Jianbo
    Wu, Yingji
    Bai, Min
    Zhan, Pei
    JOURNAL OF MOLECULAR STRUCTURE, 2017, 1129 : 17 - 22
  • [23] A Combination of 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation Studies of Benzimidazole-Quinolinone Derivatives as iNOS Inhibitors
    Zhang, Hao
    Zan, Jinhang
    Yu, Guangyun
    Jiang, Ming
    Liu, Peixun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (09) : 11210 - 11227
  • [24] Molecular engineering and activity improvement of acetylcholinesterase inhibitors: Insights from 3D-QSAR, docking, and molecular dynamics simulation studies
    Gao, Wenqi
    Ma, Xiaohong
    Yang, Huijuan
    Luan, Yuxia
    Ai, Hongqi
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 116
  • [25] Computational Modeling of Novel Phosphoinositol-3-kinase γ Inhibitors Using Molecular Docking, Molecular Dynamics, and 3D-QSAR
    Ghosh, Suparna
    Keretsu, Seketoulie
    Cho, Seung Joo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2021, 42 (08) : 1093 - 1111
  • [26] In silico design of novel potential isonicotinamide-based glycogen synthase kinase-3β (GSK-3β) inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation and ADMET studies
    Pei, Minfan
    Qian, Aiyun
    Cao, Li
    Wang, Zhenfang
    Lu, Yiping
    Yan, Chaoqun
    Liang, Taigang
    NEW JOURNAL OF CHEMISTRY, 2025, 49 (15) : 6151 - 6163
  • [27] Molecular Docking, 3D-QSAR and Molecular Dynamics Simulation Studies of Substituted Pyrimidines as Selective Covalent Janus Kinase 3 Inhibitors
    蔡晓力
    马玉卓
    赵钟祥
    张玲
    刘鹰翔
    结构化学, 2018, 37 (06) : 839 - 853
  • [28] Benzimidazole Derivatives in Identifying Novel Acetylcholinesterase Inhibitors: A Combination of 3D-QSAR, Docking and Molecular Dynamics Simulation
    El Khatabi, K.
    El-Mernissi, R.
    Aanouz, I.
    Ajana, M. A.
    Lakhlifi, T.
    Shahinozzaman, M.
    Bouachrine, M.
    PHYSICAL CHEMISTRY RESEARCH, 2022, 10 (02): : 237 - 249
  • [29] Molecular Docking, 3D-QSAR and Molecular Dynamics Simulation Studies of Substituted Pyrimidines as Selective Covalent Janus Kinase 3 Inhibitors
    Cai Xiao-Li
    Ma Yu-Zhuo
    Zhao Zhong-Xiang
    Zhang Ling
    Liu Ying-Xiang
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2018, 37 (06) : 839 - 853
  • [30] Discovery of Novel Lysine Methyltransferase (SMYD3) Inhibitors by Utilizing 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation
    Shi, YuanZe
    Chen, XiaoDie
    Li, JiaLi
    Yu, Na
    Wu, JinPing
    Zhao, XueMin
    Shu, Mao
    Lin, ZhiHua
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (10) : 1728 - 1744